Opus Genetics (IRD) Current Assets (2010 - 2026)

Opus Genetics (IRD) has 17 years of Current Assets data on file, last reported at $66.6 million in Q1 2026.

• On a quarterly basis, Current Assets rose 38.96% year-over-year to $66.6 million in Q1 2026; TTM through Mar 2026 was $66.6 million, a 38.96% increase from a year earlier, with the FY2025 full-year figure at $50.0 million, up 36.69% from the prior year.
• Current Assets for Q1 2026 stood at $66.6 million, up from $50.0 million in the prior quarter.
• Over the last five years, Current Assets for IRD reached as high as $66.6 million in Q1 2026 and fell as low as $14.6 million in Q3 2022.
• Historically, Current Assets has averaged $41.9 million across 5 years, with a median of $44.8 million in 2024.
• Across the five-year window, Current Assets plunged 37.22% in 2022 and jumped 272.14% in 2023, its largest moves.
• Year by year, Current Assets stood at $49.0 million in 2022, then grew by 10.13% to $53.9 million in 2023, then slumped by 32.14% to $36.6 million in 2024, then soared by 36.69% to $50.0 million in 2025, then soared by 33.08% to $66.6 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $66.6 million in Q1 2026, $50.0 million in Q4 2025, and $35.9 million in Q3 2025.